Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Neoplasm Metastasis 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, T-Cell, Peripheral 1Lung Neoplasms 1Locally Advanced Non-Small Cell Lung Cancer 1Liver Neoplasms 1HER2-positive Breast Cancer 1Glioma 1Glioblastoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Cisplatin 4pembrolizumab 3Nivolumab 3Fluorouracil 2Carboplatin 2toripalimab 1spartalizumab 1fludarabine phosphate 1fludarabine 1cc-486 1camrelizumab 1Vorinostat 1Valganciclovir 1Range of Motion, Articular 1Radiotherapy 1Radiosurgery 1Protons 1Platinum 1Methylprednisolone 1Medicare Part B 1Laryngoscopes 1Gemcitabine 1Docetaxel 1Cyclophosphamide 1Cetuximab 1Bevacizumab 1Azacitidine 1Adrenal Cortex Hormones 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Nasopharyngeal Carcinoma × Protons × Clear all
NCT00592501 2021-10-26

Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma

Massachusetts General Hospital

Phase 2 Completed
25 enrolled 16 charts
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡